Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system.

OBJECTIVES Emergence of multiresistant Gram-negative organisms in intensive care units (ICUs) throughout the world is a concerning problem. Therefore we undertook a study to follow the resistance patterns of the most common clinically isolated Gram-negative organisms within our ICU following an antibiotic stewardship intervention to evaluate whether a reduction in broad-spectrum antibiotics improves local antibiotic resistance patterns. METHODS This prospective study was conducted over a 7 year period within an ICU at a tertiary teaching hospital in Melbourne, Australia. All clinically isolated Gram-negative organisms were identified and extracted from the hospital pathology system. Three monthly antibiograms were created. The pre-interventional period occurred between January 2000 and June 2002 (10 quarters) and the post-interventional period was defined from July 2002 to December 2006 (18 quarters). Segmented linear regression was used to analyse for a difference in the rates of change in susceptibility. RESULTS A total of 2838 Gram-negative organisms were isolated from clinical sites from ICU patients during the study period. There was significant improvement in susceptibility of Pseudomonas to imipenem 18.3%/year [95% confidence interval (CI): 4.9-31.6; P = 0.009] and gentamicin 11.6%/year (95% CI: 1.8-21.5; P = 0.02) compared with the pre-intervention trend. Significant changes in the rates of gentamicin and ciprofloxacin susceptibility were also observed in the inducible Enterobacteriaceae group although these were less clinically significant. CONCLUSIONS This study demonstrates improved antibiotic susceptibility of ICU Gram-negative isolates including Pseudomonas following an intervention aimed at reducing broad-spectrum antibiotics.

[1]  B. Doebbeling,et al.  Antimicrobial Use Control Measures to Prevent and Control Antimicrobial Resistance in US Hospitals , 2006, Infection Control & Hospital Epidemiology.

[2]  J. F. Cade,et al.  Antibiotic Prescribing in Response to Bacterial Isolates in the Intensive Care Unit , 2005, Anaesthesia and intensive care.

[3]  R. Polk,et al.  Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. , 2004, The Journal of antimicrobial chemotherapy.

[4]  S. Pestotnik,et al.  Antibiotic use and microbial resistance in intensive care units: impact of computer-assisted decision support. , 1999, Journal of chemotherapy.

[5]  Yehuda Carmeli,et al.  Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli , 2007, Antimicrobial Agents and Chemotherapy.

[6]  N. Brahmi,et al.  Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  K. Thursky,et al.  Use of computerized decision support systems to improve antibiotic prescribing , 2006, Expert review of anti-infective therapy.

[8]  A. Peleg,et al.  Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  J. Quinn,et al.  Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. , 2003, JAMA.

[10]  D. Paterson Restrictive antibiotic policies are appropriate in intensive care units , 2003, Critical care medicine.

[11]  T. Clemmer,et al.  A computer-assisted management program for antibiotics and other antiinfective agents. , 1998, The New England journal of medicine.

[12]  I. Gould Antibiotic policies to control hospital-acquired infection. , 2008, The Journal of antimicrobial chemotherapy.

[13]  L E Nilsson,et al.  Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. , 1999, JAMA.

[14]  David L Paterson Resistance in gram-negative bacteria: enterobacteriaceae. , 2006, The American journal of medicine.

[15]  Karin A Thursky,et al.  Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. , 2006, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[16]  D. Horn,et al.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.

[17]  Peter Davey,et al.  Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. , 2003, The Journal of antimicrobial chemotherapy.

[18]  J. Black,et al.  Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. , 2008, The Journal of antimicrobial chemotherapy.

[19]  L. Goldani,et al.  Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-β-lactamase-mediated multidrug resistance: a prospective observational study , 2006, Critical care.

[20]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[21]  R. Bonomo,et al.  The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! , 2005, Current opinion in microbiology.

[22]  M. Richards,et al.  Impact of a web‐based antimicrobial approval system on broad‐spectrum cephalosporin use at a teaching hospital , 2003, The Medical journal of Australia.

[23]  C. Ramsay,et al.  Systematic Review of Antimicrobial Drug Prescribing in Hospitals , 2006, Emerging infectious diseases.

[24]  M. Kollef,et al.  Antibiotic Resistance in the Intensive Care Unit , 2001, Annals of Internal Medicine.

[25]  M. Kollef,et al.  Antimicrobial stewardship in the intensive care unit: advances and obstacles. , 2009, American journal of respiratory and critical care medicine.

[26]  Y. Carmeli,et al.  Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. , 1999, Archives of internal medicine.

[27]  J. Coast,et al.  Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness , 2002, Journal of health services research & policy.

[28]  Y. Arakawa,et al.  Global Spread of Multiple Aminoglycoside Resistance Genes , 2005, Emerging infectious diseases.